Department of Thoracic Surgery, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
J Immunol Res. 2019 Nov 4;2019:1919082. doi: 10.1155/2019/1919082. eCollection 2019.
Programmed cell death protein 1 (PD-1) and its ligand PD-L1 have attracted wide attention from researchers in the field of immunotherapy. PD-1/PD-L1 have been shown to exist in many types of cells in addition to T lymphocytes, and studies have accordingly extended from their suppressive effect on T cell activation and function to examining their role in other cells. In this review, we summarize recent research on PD-1/PD-L1 in macrophages, with the aim of furthering our understanding of PD-1/PD-L1 and their detailed roles in macrophages. This information may provide additional insights for researchers, enrich the basic theory of anti-PD-1/PD-L1 immunotherapy, and thus ultimately benefit more patients.
程序性细胞死亡蛋白 1(PD-1)及其配体 PD-L1 引起了免疫治疗领域研究人员的广泛关注。PD-1/PD-L1 除 T 淋巴细胞外,还存在于许多类型的细胞中,因此研究已从对 T 细胞激活和功能的抑制作用扩展到研究其在其他细胞中的作用。在这篇综述中,我们总结了 PD-1/PD-L1 在巨噬细胞中的最新研究,旨在进一步了解 PD-1/PD-L1 及其在巨噬细胞中的详细作用。这些信息可能为研究人员提供更多的见解,丰富抗 PD-1/PD-L1 免疫治疗的基础理论,从而最终使更多的患者受益。